Brief: Sorrento's And Yuhan's Joint Venture, Immuneoncia, Receives Approval

Yuhan

05/02/2018 13:00

Feb 5 (Reuters) - Sorrento Therapeutics Inc  SRNE.O : 
    * SORRENTO'S AND YUHAN'S JOINT VENTURE, IMMUNEONCIA, 
RECEIVES 
APPROVAL TO BEGIN CLINICAL TRIAL OF ANTI-PD-L1 MONOCLONAL 
ANTIBODY IN SOUTH KOREA 
    * SORRENTO - SOUTH KOREAN MINISTRY FOR FOOD AND DRUG SAFETY 
HAS 
APPROVED IMMUNEONCIA THERAPEUTICS' IND FOR INITIATION OF 
CLINICAL TRIALS FOR STI-A1015 
 
Source text for Eikon:  ID:nGNXOMWXPa  
Further company coverage:  SRNE.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))